Clinical characteristics and mortality in all Czech patients after pacemaker implantation in the last decade.
| Autor: | Táborský M; Department of Internal Medicine I-Cardiology, University Hospital Olomouc, Olomouc, Czech Republic., Skála T; Department of Internal Medicine I-Cardiology, University Hospital Olomouc, Olomouc, Czech Republic., Dušek L; Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic., Kautzner J; Cardiac Centre, Institute for Clinical and Experimental Medicine-IKEM, Praha, Czech Republic., Aiglová R; Department of Internal Medicine I-Cardiology, University Hospital Olomouc, Olomouc, Czech Republic., Fedorco M; Department of Internal Medicine I-Cardiology, University Hospital Olomouc, Olomouc, Czech Republic., Jarkovský J; Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic.; Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Kamenice, Czech Republic., Benešová K; Institute of Health Information and Statistics of the Czech Republic, Praha, Czech Republic.; Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Kamenice, Czech Republic., Májková P; Faculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Kamenice, Czech Republic. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Dec 08; Vol. 10, pp. 1248145. Date of Electronic Publication: 2023 Dec 08 (Print Publication: 2023). |
| DOI: | 10.3389/fcvm.2023.1248145 |
| Abstrakt: | Background and Aims: Analysis of mortality from the national health registries and data from a specific central registry dealing with the implantation of pacemakers (REPACE) in Czech patients. Methods and Results: Retrospective observational analysis of pacemakers' implantation in all Czech patients [ n = 82,791; 47,070 (56.9%) men, 75.9 ± 10.4 years old] between 2010 and 2021. Almost 114,000 pacemakers were implanted between 2010 and 2021, of which 27.9% were single-chamber, 67.4% were dual-chamber and 4.6% were biventricular. The annual number of implantations has been steadily increasing with a 6% annual decline in 2020 with increased mortality and reductions in care provided, likely related to COVID-19. The observed 5-year relative survival was 88.6% (overall survival 60.6%) and the 10-year relative survival was 75.9% (overall survival 32.7%). Causes of death 5ary according to the age of the patient. The highest difference 1n the reported numbers in the REPACE Registry did not exceed 2% in comparison with the National Register of Reimbursed Health Services. Conclusion: This study followed all Czech patients with pacemaker's implantation in between 2010 and 2021. The annual number of 1mplantations has been steadily 1ncreasing. Patients with implanted pacemakers had a significantly higher mortality than the average population. Number of patients in the registry corresponded almost perfectly with the National Register of Reimbursed Health Services. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (© 2023 Táborský, Skála, Dušek, Kautzner, Aiglová, Fedorco, Jarkovský, Benešová and Májková.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|